Chlorogenic Acid Attenuates Bleomycin-Induced Pulmonary Fibrosis in a Murine Model by Modulating TGF-β1 Expression
Advances in Respiratory Medicine · 2026
DOI: 10.3390/arm94050060 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advances in Respiratory Medicine, 2026. Verfasst von Juan Manuel Velázquez-Enríquez und 9 weiteren Autor:innen. Beteiligte Einrichtung: Laboratorio de Biomedicina Traslacional y Sistemas, Centro de Investigación en Nutrición y Alimentación, Universidad del Istmo, Carretera Transísmica…. Hauptthemen laut MEDLINE: Chlorogenic Acid, Transforming Growth Factor beta1, Pulmonary Fibrosis. Die Arbeit nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: CONAHCyT.
Abstract (Originalsprache)
Background
Idiopathic pulmonary fibrosis (IPF) is a progressive interstitial lung disease driven by aberrant extracellular matrix deposition, with the activity of transforming growth factor-beta 1 (TGF-β1) orchestrating fibrogenesis. Current therapies are limited by severe adverse effects, highlighting the unmet need for safer treatments. In this study, the therapeutic potential of chlorogenic acid (CGA) in a murine model of pulmonary fibrosis was evaluated.
Methods
Pathology was induced on day 0 via subcutaneous osmotic minipumps delivering bleomycin (BLM) for one week, followed by pump removal on day 10. Therapeutic interventions with intragastric CGA (60 mg/kg) were administered daily from days 14 to 20. Lung tissue samples obtained on day 21 were analyzed via histological, immunohistochemical, and RT–PCR methods.
Results
Histological analysis via H&E and Masson’s trichrome staining revealed that CGA treatment significantly attenuated alveolar thickening, restored the alveolar space, and reduced the total cell density and Ashcroft fibrosis score. Furthermore, CGA markedly decreased collagen deposition. Quantitative RT–PCR and immunohistochemical assays revealed that CGA effectively decreased the expression of Col1a1, TGF-β1, and the myofibroblast marker alpha-smooth muscle actin (α-SMA).
Conclusions
CGA exerts important therapeutic effects by decreasing the expression of TGF-β1 and the activation of myofibroblasts, indicating that this natural polyphenol is a promising candidate for mitigating the progression of pulmonary fibrosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratorio de Biomedicina Traslacional y Sistemas, Centro de Investigación en Nutrición y Alimentación, Universidad del Istmo, Carretera Transísmica Juchitán, La Ventosa km. 14, La Ventosa C.P. 70102, Oaxaca, Mexico.
- Laboratorio de Fibrosis y Cáncer, Facultad de Medicina y Cirugía, Universidad Autónoma Benito Juárez de Oaxaca, Ex Hacienda de Aguilera S/N, Sur, San Felipe del Agua, Oaxaca de Juárez C.P. 68020, Oaxaca, Mexico.
- Laboratorio de Diagnóstico Molecular, Facultad de Medicina, Universidad Autónoma de Guerrero, Avenida Solidaridad S/N Hornos Insurgentes, Acapulco C.P. 39300, Guerrero, Mexico.
- Laboratorio de Enfermedades Hepáticas, Instituto Nacional de Medicina Genómica-INMEGEN, Mexico City C.P. 14610, Mexico.
- Dirección Adjunta de Investigación Humanística y Científica, Consejo Nacional de Humanidades, Ciencias y Tecnologías-SECIHTI, Mexico City C.P. 03940, Mexico.
- SECIHTI-Facultad de Medicina y Cirugía, Universidad Autónoma Benito Juárez de Oaxaca, Ex Hacienda de Aguilera S/N, Sur, San Felipe del Agua, Oaxaca C.P. 68020, Mexico.
ORCID-Profile: Juan Manuel Velázquez-Enríquez, Edilburga Reyes-Jiménez, Jaime Arellanes-Robledo, Carlos Alberto Matias-Cervantes, María Del Socorro Pina-Canseco, Rafael Baltiérrez-Hoyos
Förderung
- CONAHCyT
Zitieren
APA
Velázquez-Enríquez, J. M., Ramírez-Hernández, A. A., Santos-Álvarez, J. C., Reyes-Jiménez, E., Arcos-Román, A., Arellanes-Robledo, J., Matias-Cervantes, C. A., Pina-Canseco, M. D. S., Vásquez-Garzón, V. R., & Baltiérrez-Hoyos, R. (2026). Chlorogenic Acid Attenuates Bleomycin-Induced Pulmonary Fibrosis in a Murine Model by Modulating TGF-β1 Expression. Advances in Respiratory Medicine. https://doi.org/10.3390/arm94050060
Vancouver
Velázquez-Enríquez JM, Ramírez-Hernández AA, Santos-Álvarez JC, Reyes-Jiménez E, Arcos-Román A, Arellanes-Robledo J, et al. Chlorogenic Acid Attenuates Bleomycin-Induced Pulmonary Fibrosis in a Murine Model by Modulating TGF-β1 Expression. Advances in Respiratory Medicine. 2026. doi:10.3390/arm94050060
BibTeX
@article{VelzquezEnrquez2026,
author = {Velázquez-Enríquez, Juan Manuel and Ramírez-Hernández, Alma Aurora and Santos-Álvarez, Jovito César and Reyes-Jiménez, Edilburga and Arcos-Román, Antonio and Arellanes-Robledo, Jaime and Matias-Cervantes, Carlos Alberto and Pina-Canseco, María Del Socorro and Vásquez-Garzón, Verónica Rocío and Baltiérrez-Hoyos, Rafael},
title = {Chlorogenic Acid Attenuates Bleomycin-Induced Pulmonary Fibrosis in a Murine Model by Modulating TGF-β1 Expression},
journal = {Advances in Respiratory Medicine},
year = {2026},
doi = {10.3390/arm94050060}
}
EUVIMED